Literature DB >> 23479069

Clinical outcomes following prolonged refractory status epilepticus (PRSE).

R D Kilbride1, A S Reynolds, J P Szaflarski, L J Hirsch.   

Abstract

BACKGROUND: To define the clinical profile and outcome of patients in prolonged refractory status epilepticus (PRSE), and investigate possible predictors of outcome.
METHODS: We reviewed 63 consecutive patients with PRSE cared for in the medical and neurointensive care units of three academic medical centers over a 9-year period. For this multi-center retrospective cohort study, PRSE was defined as SE that persisted despite at least 1 week of induced coma. Variables examined for their relationship to outcome included etiology, EEG, neuroimaging, and age.
RESULTS: Forty-two (66%) of 63 patients in PRSE survived to discharge from hospitalization. Fourteen (22%) patients had a good outcome (mRS ≤ 3) at last available follow up (at least 6 months post-PRSE). Of these, 6 (10%) individuals had no significant disability and were able to carry out all usual activities (mRS = 1). Normal neuroimaging and a reactive EEG at onset of PRSE were associated with good outcome. Good or excellent clinical outcomes were possible in patients in PRSE for up to 79 days, and in patients up to 69 years old.
CONCLUSIONS: Good outcome is not unusual in PRSE, including in some older patients, in a variety of diagnoses, and despite months of coma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23479069     DOI: 10.1007/s12028-013-9823-4

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  11 in total

1.  A "malignant" variant of status epilepticus.

Authors:  Martin Holtkamp; Jalal Othman; Katharina Buchheim; Florian Masuhr; Eva Schielke; Hartmut Meierkord
Journal:  Arch Neurol       Date:  2005-09

2.  Etiology and prognosis of alpha coma.

Authors:  E J Austin; R J Wilkus; W T Longstreth
Journal:  Neurology       Date:  1988-05       Impact factor: 9.910

3.  Survivors and nonsurvivors of very prolonged status epilepticus.

Authors:  Frank W Drislane; M Raquel Lopez; Andrew S Blum; Donald L Schomer
Journal:  Epilepsy Behav       Date:  2011-08-16       Impact factor: 2.937

Review 4.  Status epilepticus.

Authors:  D H Lowenstein; B K Alldredge
Journal:  N Engl J Med       Date:  1998-04-02       Impact factor: 91.245

5.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

6.  Refractory status epilepticus: frequency, risk factors, and impact on outcome.

Authors:  Stephan A Mayer; Jan Claassen; Johnny Lokin; Felicia Mendelsohn; Lyle J Dennis; Brian-Fred Fitzsimmons
Journal:  Arch Neurol       Date:  2002-02

7.  A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia.

Authors:  R J DeLorenzo; W A Hauser; A R Towne; J G Boggs; J M Pellock; L Penberthy; L Garnett; C A Fortner; D Ko
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

8.  EEG and clinical associations with mortality in comatose patients in a general intensive care unit.

Authors:  G B Young; J H Kreeft; R S McLachlan; J Demelo
Journal:  J Clin Neurophysiol       Date:  1999-07       Impact factor: 2.177

9.  Functional and cognitive outcome in prolonged refractory status epilepticus.

Authors:  Alex D Cooper; Jeffrey W Britton; Alejandro A Rabinstein
Journal:  Arch Neurol       Date:  2009-12

10.  Status epilepticus. Causes, clinical features and consequences in 98 patients.

Authors:  M J Aminoff; R P Simon
Journal:  Am J Med       Date:  1980-11       Impact factor: 4.965

View more
  16 in total

1.  Finding the Lesser of Two Evils: Treating Refractory Status Epilepticus.

Authors:  Lawrence J Hirsch
Journal:  Epilepsy Curr       Date:  2015 Nov-Dec       Impact factor: 7.500

Review 2.  Refractory and super-refractory status epilepticus--an update.

Authors:  Sara Hocker; William O Tatum; Suzette LaRoche; W David Freeman
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

3.  Summary of the 2016 Partners Against Mortality in Epilepsy (PAME) Conference.

Authors: 
Journal:  Epilepsy Curr       Date:  2016 Nov-Dec       Impact factor: 7.500

4.  New-onset refractory status epilepticus: Etiology, clinical features, and outcome.

Authors:  Nicolas Gaspard; Brandon P Foreman; Vincent Alvarez; Christian Cabrera Kang; John C Probasco; Amy C Jongeling; Emma Meyers; Alyssa Espinera; Kevin F Haas; Sarah E Schmitt; Elizabeth E Gerard; Teneille Gofton; Peter W Kaplan; Jong W Lee; Benjamin Legros; Jerzy P Szaflarski; Brandon M Westover; Suzette M LaRoche; Lawrence J Hirsch
Journal:  Neurology       Date:  2015-08-21       Impact factor: 9.910

5.  What Should We Prescribe for Acute Seizures When There Is No Intravenous Access?

Authors:  Jerzy P Szaflarski
Journal:  Epilepsy Curr       Date:  2016 May-Jun       Impact factor: 7.500

Review 6.  Treatment of Refractory and Super-refractory Status Epilepticus.

Authors:  Samhitha Rai; Frank W Drislane
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

7.  Development and Feasibility Testing of a Critical Care EEG Monitoring Database for Standardized Clinical Reporting and Multicenter Collaborative Research.

Authors:  Jong Woo Lee; Suzette LaRoche; Hyunmi Choi; Andres A Rodriguez Ruiz; Evan Fertig; Jeffrey M Politsky; Susan T Herman; Tobias Loddenkemper; Arnold J Sansevere; Pearce J Korb; Nicholas S Abend; Joshua L Goldstein; Saurabh R Sinha; Keith E Dombrowski; Eva K Ritzl; Michael B Westover; Jay R Gavvala; Elizabeth E Gerard; Sarah E Schmitt; Jerzy P Szaflarski; Kan Ding; Kevin F Haas; Richard Buchsbaum; Lawrence J Hirsch; Courtney J Wusthoff; Jennifer L Hopp; Cecil D Hahn
Journal:  J Clin Neurophysiol       Date:  2016-04       Impact factor: 2.177

8.  Systematic Evaluation of Research Priorities in Critical Care Electroencephalography.

Authors:  Zubeda Sheikh; Olga Selioutski; Olga Taraschenko; Emily J Gilmore; M Brandon Westover; Adam B Cohen
Journal:  J Clin Neurophysiol       Date:  2022-01-20       Impact factor: 2.590

Review 9.  Electrophysiologic monitoring in acute brain injury.

Authors:  Jan Claassen; Paul Vespa
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

Review 10.  Markers in Status Epilepticus Prognosis.

Authors:  Ayham Alkhachroum; Caroline A Der-Nigoghossian; Clio Rubinos; Jan Claassen
Journal:  J Clin Neurophysiol       Date:  2020-09       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.